BIRDX
Price
$10.45
Change
-$0.07 (-0.67%)
Updated
Sep 20 closing price
RRGRX
Price
$7.66
Change
-$0.04 (-0.52%)
Updated
Sep 20 closing price
Ad is loading...

BIRDX vs RRGRX

Header iconBIRDX vs RRGRX Comparison
Open Charts BIRDX vs RRGRXBanner chart's image
iShares Developed Real Estate Idx Instl
Price$10.45
Change-$0.07 (-0.67%)
VolumeN/A
CapitalizationN/A
DWS RREEF Global Real Estate Secc R6
Price$7.66
Change-$0.04 (-0.52%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BIRDX vs RRGRX Comparison Chart
Loading...
VS
BIRDX vs. RRGRX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIRDX is a StrongSell and RRGRX is a Buy.

FUNDAMENTALS
Fundamentals
BIRDX has more cash in the bank: 3.09B vs. RRGRX (182M). BIRDX pays higher dividends than RRGRX: BIRDX (3.02) vs RRGRX (1.47). BIRDX was incepted earlier than RRGRX: BIRDX (9 years) vs RRGRX (8 years). RRGRX is a more actively managed with annual turnover of: 82.00 vs. BIRDX (3.00). RRGRX has a lower initial minimum investment than BIRDX: RRGRX (0) vs BIRDX (2000000). RRGRX (26.65) and BIRDX (26.24) have marching annual gain over last year. BIRDX return over 5 years is better than : 10.01 vs. RRGRX (-4.77).
BIRDXRRGRXBIRDX / RRGRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years8 years-
Gain YTD11.55212.75691%
Front LoadN/AN/A-
Min. Initial Investment20000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.09B182M1,696%
Annual Yield % from dividends3.021.47206%
Returns for 1 year26.2426.6598%
Returns for 3 years-0.62-8.287%
Returns for 5 years10.01-4.77-210%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZTA49.28-0.21
-0.43%
Azenta
METC10.13-0.09
-0.88%
Ramaco Resources
CE126.90-3.19
-2.45%
Celanese Corp
GOEV1.02-0.03
-2.86%
Canoo
PMCB1.62-0.43
-20.98%
PharmaCyte Biotech